Deep Dive: Drug Prices and Access to Medicine
Setup
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs doubled from 2013 to 2014. That puts them far out of reach for countess ailing people, including many with decent insurance. The industry argues that it needs the revenue for the complex and expensive research that leads to better treatments, but pharmaceutical executives are being pilloried in editorials and Congressional hearings, and consumer groups say marketing and profit are the real drivers of price. What’s behind the cost of drugs? What are the options for people who can’t pay it?
Speakers
-
Kenneth DavisCEO of Mount Sinai Health System -
Alan WeilEditor-in-Chief of Health Affairs -
Kiah WilliamsCo-Founder and Director, SIRUM -
Lisa GillDeputy Content Editor, Best Buy Drugs, Consumer Reports (Festival Unde... -
Ezekiel EmanuelFormer Member of President Biden's Transition COVID-19 Advisory Board -
Geoffrey ChaikenCo-Founder and CEO, Blink Health -
Kirsten AxelsenVice President Global Policy, Pfizer (Festival Underwriter)
Explore More
Health
Over the last nine years, Aspen Ideas: Health has welcomed nearly 700 inspiring women leaders to our stages to share their bold approaches to better health. In honor of Women'...
From the Supreme Court's ruling on abortion rights to public health's role in addressing gun violence to the devastating human toll of the war in Ukraine, this year's Aspen Id...
In America, millions of people struggle with mental health including depression, anxiety, and more — all further exacerbated by living through a pandemic. The National Allianc...
What do Sherlock Holmes and an internist have in common? Meet Lisa Sanders, the doctor reimagining the way medical mysteries are diagnosed. She explains why providers struggl...
The "Great Resignation" has impacted nursing and created a healthcare crisis for us all. What can be done to drive real change and create a supportive work environment where n...
From the "War on Cancer" to the "Cancer Moonshot", extraordinary progress continues to be made in the prevention, diagnosis, and treatment of cancer. Research is driving life-...
In the wake of transformative biopharmaceutical innovation and breakthroughs, Americans need a health care system that ensures these life-saving breakthroughs reach all patien...
A silent epidemic of chronic illnesses, including autoimmune disease, post-treatment Lyme disease syndrome, and long COVID, afflicts tens of millions of Americans. Best-sellin...
Achieving vaccine equity requires authentically communicating with and listening to all communities. As healthcare leaders, we must go where the community is to hear their sto...
Health workers often face grueling working conditions. They regularly confront trauma, work long hours, are exposed to physical danger, and must keep pace with the demands of...
